-
1
المؤلفون: Ayse Engin, Akif Turna, Fehim Esen, Melek Agkoc, Duygu Ilke Cikman, Omer Faruk Saglam, Gunnur Deniz, Esin Cetin Aktas
المصدر: Tumori Journal. 109:97-104
مصطلحات موضوعية: Cancer Research, Oncology, General Medicine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92390f93f74808af9f12117426c7f275
https://doi.org/10.1177/03008916211064643 -
2
المؤلفون: Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
المساهمون: ŞİMŞEK, MELİH
المصدر: Cancer Investigation. 39:473-481
مصطلحات موضوعية: Oncology, Turkey, retrospective study, T-DM1, diarrhea, heart failure, thrombocytopenia, 0302 clinical medicine, aspartate aminotransferase, infusion related reaction, estrogen, genetics, Neoplasm Metastasis, cancer survival, skin and connective tissue diseases, Aged, 80 and over, progression free survival, portal hypertension, clinical trial, General Medicine, nausea, anemia, Metastatic breast cancer, 030220 oncology & carcinogenesis, immunological antineoplastic agent, oral mucositis, musculoskeletal diseases, medicine.medical_specialty, progesterone, Article, multiple cycle treatment, paresthesia, hypomagnesemia, 03 medical and health sciences, turkey (bird), neutropenia, metastasis, Humans, human, acne, cystitis, neoplasms, human epidermal growth factor receptor 2 positive breast cancer, Aged, Retrospective Studies, trastuzumab emtansine, hypophosphatemia, leukopenia, ERBB2 protein, human, thromboembolism, hyperkalemia, medicine.disease, major clinical study, Survival Analysis, drug efficacy, multicenter study, 030104 developmental biology, chemistry, epidermal growth factor receptor 2, fatigue, proteinuria, disease activity, drug tolerability, drug hypersensitivity, 0301 basic medicine, vomiting, Cancer Research, drug safety, hyponatremia, Survival, Receptor, ErbB-2, very elderly, efficacy, hyperuricemia, hypocalcemia, Ado-Trastuzumab Emtansine, Turkey (republic), chemistry.chemical_compound, Antineoplastic Agents, Immunological, brain metastasis, pain, lapatinib, hypernatremia, breast tumor, Middle Aged, visceral metastasis, humanities, trastuzumab, Treatment Outcome, gamma glutamyltransferase, immunohistochemistry, Female, real world experience.-, Cancer investigation, ss.1-22, 2021 [Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M. , Seydaoğlu G., Bilici M., Şimşek M., Tekin S. B. , Çalikuşu Z., et al., -Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer], bilirubin, alkaline phosphatase, Receptor, Adult, congenital, hereditary, and neonatal diseases and abnormalities, side effect, alanine aminotransferase, overall survival, Breast Neoplasms, spine metastasis, delirium, male, pertuzumab, acute kidney failure, Internal medicine, hypokalemia, medicine, pneumonia, controlled study, fluorescence in situ hybridization, business.industry, liver failure, hypercalcemia, hypertransaminasemia, toxicity, alopecia, hand foot syndrome, human tissue, real-world experience, clinical feature, febrile neutropenia, hypoglycemia, Trastuzumab emtansine, hyperglycemia, business, metabolism
-
3
المؤلفون: Fuat Demirelli, Nilay Sengul Samanci, Duygu Ilke Cikman, Nihan Şentürk Öztaş, Sahin Bedir, Emir Celik, Ezgi Degerli, Kerem Oruc, Nebi Serkan Demirci, Mehmet Karadag, Sumeyra Derin
المصدر: Journal of Oncology Pharmacy Practice. 27:1665-1673
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Erlotinib Hydrochloride, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Effective treatment, Pharmacology (medical), Renal Insufficiency, Lung cancer, Protein Kinase Inhibitors, business.industry, medicine.disease, ErbB Receptors, 030104 developmental biology, Egfr mutation, 030220 oncology & carcinogenesis, Mutation, Quinazolines, Non small cell, Erlotinib, Neoplasm Recurrence, Local, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8feca6a0ffb74fd012c8345b45b6387
https://doi.org/10.1177/1078155220964895